<?xml version="1.0" ?>
<document id="27458054">
  <sentence id="27458054.s0" text="As ubiquitination is a versatile post-translational modification that can affect target turnover, sub-cellular localisation or activity, it is likely that diverse substrates may be differentially affected by protein polyubiquitination-mediated ubiquitination, reflecting its multi-faceted roles in muscle physiology, cancer and immunity.">
    <entity charOffset="208-234" id="27458054.s0.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="317-323" id="27458054.s0.e1" ontology_id="HP_0002664" text="cancer" type="HP"/>
    <pair e1="27458054.s0.e0" e2="27458054.s0.e1" id="27458054.s0.p0" relation="true"/>
  </sentence>
  <sentence id="27458054.s1" text="In this review, we will focus on the ability of protein polyubiquitination to mark specific substrates for proteasomal degradation discussing how the TRIM32-proteasome axis may (i) be important for muscle homeostasis and for the pathogenesis of muscular dystrophy; and (ii) define either an oncogenic or tumour suppressive role for TRIM32 in the context of different types of cancer">
    <entity charOffset="48-74" id="27458054.s1.e0" ontology_id="GO_0000209" text="protein polyubiquitination" type="GO"/>
    <entity charOffset="304-310" id="27458054.s1.e1" ontology_id="HP_0002664" text="tumour" type="HP"/>
    <pair e1="27458054.s1.e0" e2="27458054.s1.e1" id="27458054.s1.p0" relation="true"/>
  </sentence>
</document>
